Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.

R. Huijgen; E.J. Abbink; E. Bruckert; A.F.H. Stalenhoef; B.P. Imholz; P.N. Durrington; M.D. Trip; M. Eriksson; F.L.J. Visseren; J.R. Schaefer; X for the Triple Study Group; J.J. Kastelein

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.

Translated title of the contribution: Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.

R. Huijgen, E.J. Abbink, E. Bruckert, A.F.H. Stalenhoef, B.P. Imholz, P.N. Durrington, M.D. Trip, M. Eriksson, F.L.J. Visseren, J.R. Schaefer, X for the Triple Study Group, J.J. Kastelein

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
Original language	Undefined/Unknown
Pages (from-to)	615-625
Number of pages	11
Journal	Clinical Therapeutics
Volume	32
Issue number	4
Publication status	Published - 2010

Cite this

Huijgen, R., Abbink, E. J., Bruckert, E., Stalenhoef, A. F. H., Imholz, B. P., Durrington, P. N., Trip, M. D., Eriksson, M., Visseren, F. L. J., Schaefer, J. R., for the Triple Study Group, X., & Kastelein, J. J. (2010). Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial. Clinical Therapeutics, 32(4), 615-625.

@article{60faac51bf0c4d85b78248df598f7628,

title = "Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.",

author = "R. Huijgen and E.J. Abbink and E. Bruckert and A.F.H. Stalenhoef and B.P. Imholz and P.N. Durrington and M.D. Trip and M. Eriksson and F.L.J. Visseren and J.R. Schaefer and {for the Triple Study Group}, X and J.J. Kastelein",

year = "2010",

language = "Undefined/Unknown",

volume = "32",

pages = "615--625",

journal = "Clinical Therapeutics",

issn = "0149-2918",

publisher = "Excerpta Medica",

number = "4",

}

Huijgen, R, Abbink, EJ, Bruckert, E, Stalenhoef, AFH, Imholz, BP, Durrington, PN, Trip, MD, Eriksson, M, Visseren, FLJ, Schaefer, JR, for the Triple Study Group, X & Kastelein, JJ 2010, 'Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.', Clinical Therapeutics, vol. 32, no. 4, pp. 615-625.

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial. / Huijgen, R.; Abbink, E.J.; Bruckert, E. et al.
In: Clinical Therapeutics, Vol. 32, No. 4, 2010, p. 615-625.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.

AU - Huijgen, R.

AU - Abbink, E.J.

AU - Bruckert, E.

AU - Stalenhoef, A.F.H.

AU - Imholz, B.P.

AU - Durrington, P.N.

AU - Trip, M.D.

AU - Eriksson, M.

AU - Visseren, F.L.J.

AU - Schaefer, J.R.

AU - for the Triple Study Group, X

AU - Kastelein, J.J.

PY - 2010

Y1 - 2010

M3 - Article

SN - 0149-2918

VL - 32

SP - 615

EP - 625

JO - Clinical Therapeutics

JF - Clinical Therapeutics

IS - 4

ER -